Your browser doesn't support javascript.
loading
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
Murugan, Paari; Jia, Liwei; Dinatale, Renzo G; Assel, Melissa; Benfante, Nicole; Al-Ahmadie, Hikmat A; Fine, Samson W; Gopalan, Anuradha; Sarungbam, Judy; Sirintrapun, S Joseph; Hakimi, A Ari; Russo, Paul; Chen, Ying-Bei; Tickoo, Satish K; Reuter, Victor E.
Afiliación
  • Murugan P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Jia L; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Dinatale RG; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Assel M; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Benfante N; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Al-Ahmadie HA; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Fine SW; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gopalan A; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sarungbam J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sirintrapun SJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hakimi AA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Russo P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chen YB; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tickoo SK; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Reuter VE; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mod Pathol ; 35(6): 825-835, 2022 06.
Article en En | MEDLINE | ID: mdl-34949764
The morphologic spectrum of type 1 papillary renal cell carcinoma (PRCC) is not well-defined, since a significant proportion of cases have mixed type 1 and 2 histology. We analyzed 199 cases of PRCC with any (even if focal) type 1 features, with a median follow-up of 12 years, to identify clinicopathological features associated with outcome. Ninety-five tumors (48%) of the cohort contained some type 2 component (median amount: 25%; IQR: 10%, 70%). As a group they showed high rates of progression-free (PFS) and cancer-specific survival (CSS). Tumor size, mitotic rate, lymphovascular invasion, sarcomatoid differentiation, sheet-like architecture, and lack of tumor circumscription were significantly associated with CSS (p ≤ 0.015) on univariate analysis. While predominant WHO/ISUP nucleolar grade was associated with PFS (p = 0.013) and CSS (p = 0.030), the presence of non-predominant (<50%) nucleolar grade did not show association with outcome (p = 0.7). PFS and CSS showed no significant association with the presence or the amount of type 2 morphology. We compared the molecular alterations in paired type 1 and type 2 areas in a subset of 22 cases with mixed type 1 and 2 features and identified 12 recurrently mutated genes including TERT, ARID1A, KDM6A, KMT2D, NFE2L2, MET, APC, and TP53. Among 78 detected somatic mutations, 61 (78%) were shared between the paired type 1 and type 2 areas. Copy number alterations, including chromosome 7 and 17 gains, were similar between type 1 and 2 areas. These findings support that type 2 features in a PRCC with mixed histology represent either morphologic variance or clonal evolution. Our study underscores the notion that PRCC with any classic type 1 regions is best considered as type 1 PRCC and assigned the appropriate WHO/ISUP nucleolar grade. It provides additional evidence that type 2 PRCC as a separate category should be re-assessed and likely needs to be abandoned.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mod Pathol Asunto de la revista: PATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mod Pathol Asunto de la revista: PATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos